News and Trends 6 Jul 2023 AstraZeneca non-small cell lung cancer drug meets primary endpoint …majority being low grade. Some Grade 5 events were observed. Datopotamab deruxtecan is a specifically engineered TROP2-directed DXd antibody drug conjugate (ADC) being jointly developed by AstraZeneca and Daiichi Sankyo…. July 6, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 1 Feb 2023 Foundation for the National Institutes of Health: partnering to tackle cancer …that prevents disease or catches it early enough for treatment to be more effective. What are some of the research areas with the best hopes of making a difference, and… February 1, 2023 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2023 New therapy for prevention and treatment of COVID-19 …of the SARS-CoV-2 spike that mediates membrane fusion, an essential step during virus entry. XVR013 prevents the membrane fusion, and protects against SARS-CoV-2 infection in vitro and in an in… March 13, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Expert Advice 2 Mar 2023 5 steps to strategic partnerships for healthtech startups …royalties. Attend industry events and meetups Potential partners can often be found through conferences, which are typically centered around either business development or R&D. They provide a platform for companies… March 2, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2024 Is China the future of biotech? Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a controversy involving… December 13, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 2 May 2025 From pandemic spotlight to post-COVID crossroads: What happened to these biotech players? …days ago, French health authorities temporarily suspended the use of IXCHIQ in adults aged 65 and older following reports of serious adverse events, including one death, during a vaccination campaign… May 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 5 Apr 2017 Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor …belongs to the difficult-to-drug class of GPCRs and binds the anti-inflammatory molecule adenosine, whose expression is often increased within the tumor microenvironment. By stimulating A2A receptors, adenosine prevents T-cells within… April 5, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2023 Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered …trial met the primary endpoint. While there were no serious adverse events that were drug-related, according to the press release, one treatment-related discontinuation took place. “We are very pleased with… December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Oct 2020 Universal Flu Vaccines Yield Second Clinical Failure This Year …the placebo in the phase III trial, when you’d normally expect occasional adverse events such as fever. This could indicate the dose was lower than it should have been to… October 29, 2020 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 28 Jan 2017 Microbes Control the Massive Turbine Hall at London’s Tate Modern …yeast. In turn, the food the microbes receive alters their movement patterns, which are measured and used by computer software to control all the events going on at the hall…. January 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Nov 2022 UCB publishes Lennox-Gastaut syndrome study data …study also demonstrated that FINTEPLA was generally well tolerated. The most common treatment-emergent adverse events observed in the OLE were decreased appetite, fatigue, nasopharyngitis, and seizure. The cardiovascular safety in… November 23, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Sep 2025 Navigating German biotech: 14 key players to know …fewer severe drug-related adverse events than with everolimus. On the regulatory and commercial front, ITM plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration… September 23, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email